It is also the active ingredient in Ozempic® for diabetes. Semaglutide is a once weekly injection that has helped people lose and maintain weight loss in combination with diet and exercise.

Semaglutide is a GLP-1 agonist that promotes appetite suppression by delaying gastric emptying.
This helps to increase fullness, lower glucose and even decreases the desire for fatty and/or sugary foods.
In a recent 2021 study, non-diabetic patients reported as much as 20% weight loss.

On average patients had a weight loss of 33lbs!

.
In 2021, the results of a study with semaglutide for non-diabetic patients for weight loss were published.

More than 50% of trial participants lost 15% of their body weight, Between 33% to 40% lost 20% of their body weight.

Other benefits were noted such as decreased cardiac risk factors, decreased lipid profile, BMI, systolic blood pressure and glucose.